IL33 and colorectal carcinoma: It remains to be elucidated how IL-33 contributes to the described pro- or anti-tumorigenic functions of ILC2s in CRC and other cancers, and if the cytokine milieu in these tissues allows for IL-33-mediated enhancement of NK cell responses.